| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CL | Common Stock | Award | $0 | +56.6K | +20.63% | $0.00 | 331K | Feb 15, 2024 | Direct | F1 |
| transaction | CL | Common Stock | Sale | -$2.5M | -29.8K | -8.99% | $84.06 | 301K | Feb 16, 2024 | Direct | F2, F3 |
| transaction | CL | Common Stock | Options Exercise | $3.78M | +55.5K | +18.41% | $68.16 | 357K | Feb 20, 2024 | Direct | F4 |
| transaction | CL | Common Stock | Sale | -$1.22M | -14.5K | -4.05% | $84.41 | 342K | Feb 20, 2024 | Direct | F5, F6 |
| transaction | CL | Common Stock | Sale | -$4.67M | -55.5K | -16.21% | $84.17 | 287K | Feb 20, 2024 | Direct | F7, F8 |
| holding | CL | Common Stock | 51.7K | Feb 15, 2024 | By Issuer's 401(k) Plan Trustee | ||||||
| holding | CL | Common Stock | 52K | Feb 15, 2024 | By Spouse Trust | ||||||
| holding | CL | Common Stock | 335 | Feb 15, 2024 | By Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CL | Stock Option (Right to Buy) | Options Exercise | $0 | -55.5K | -100% | $0.00* | 0 | Feb 20, 2024 | Common Stock | 55.5K | $68.16 | Direct | F4, F9 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock. |
| F2 | Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 16, 2023. |
| F3 | Weighted average price, as these shares were sold in multiple transactions at prices ranging from $83.93 to $84.2019, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | Exercise of stock options awarded under the issuer's incentive compensation plan. |
| F5 | Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to vesting of a restricted stock unit award under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 16, 2023. |
| F6 | Weighted average price, as these shares were sold in multiple transactions at prices ranging from $84.35 to $84.5203, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. |
| F8 | Weighted average price, as these shares were sold in multiple transactions at prices ranging from $83.70 to $84.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F9 | Option became exercisable in one-third increments beginning on the first anniversary of the September 13, 2018 grant date. |